These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17694480)

  • 1. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.
    Bech P
    Pharmacopsychiatry; 2007 Jul; 40(4):163-8. PubMed ID: 17694480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin: dose-response relationship in generalized anxiety disorder.
    Boschen MJ
    Pharmacopsychiatry; 2012 Mar; 45(2):51-6. PubMed ID: 22086745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
    Feltner DE; Crockatt JG; Dubovsky SJ; Cohn CK; Shrivastava RK; Targum SD; Liu-Dumaw M; Carter CM; Pande AC
    J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    Lydiard RB; Rickels K; Herman B; Feltner DE
    Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
    Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
    Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
    Baldwin DS; Schweizer E; Xu Y; Lyndon G
    Eur Neuropsychopharmacol; 2012 Feb; 22(2):137-42. PubMed ID: 21839620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of gastrointestinal symptoms on response to pregabalin in generalized anxiety disorder: results of a six-study combined analysis.
    Stein DJ; Bruce Lydiard R; Herman BK; Mandel FS
    Int Clin Psychopharmacol; 2009 May; 24(3):126-32. PubMed ID: 19352198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia.
    Montgomery SA; Herman BK; Schweizer E; Mandel FS
    Int Clin Psychopharmacol; 2009 Jul; 24(4):214-22. PubMed ID: 19542983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.
    Both C; Kojda G; Lange-Asschenfeldt C
    Expert Rev Neurother; 2014 Jan; 14(1):29-38. PubMed ID: 24308277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis.
    Montgomery SA; Lyndon G; Almas M; Whalen E; Prieto R
    Int Clin Psychopharmacol; 2017 Jan; 32(1):41-48. PubMed ID: 27583543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ; Mandel FS; Schweizer E
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.